Article ; Online: Discovery of Antivirals Using Phage Display.
2021 Volume 13, Issue 6
Abstract: The latest coronavirus disease outbreak, COVID-19, has brought attention to viral infections which have posed serious health threats to humankind throughout history. The rapid global spread of COVID-19 is attributed to the increased human mobility of ... ...
Abstract | The latest coronavirus disease outbreak, COVID-19, has brought attention to viral infections which have posed serious health threats to humankind throughout history. The rapid global spread of COVID-19 is attributed to the increased human mobility of today's world, yet the threat of viral infections to global public health is expected to increase continuously in part due to increasing human-animal interface. Development of antiviral agents is crucial to combat both existing and novel viral infections. Recently, there is a growing interest in peptide/protein-based drug molecules. Antibodies are becoming especially predominant in the drug market. Indeed, in a remarkably short period, four antibody therapeutics were authorized for emergency use in COVID-19 treatment in the US, Russia, and India as of November 2020. Phage display has been one of the most widely used screening methods for peptide/antibody drug discovery. Several phage display-derived biologics are already in the market, and the expiration of intellectual property rights of phage-display antibody discovery platforms suggests an increment in antibody drugs in the near future. This review summarizes the most common phage display libraries used in antiviral discovery, highlights the approaches employed to enhance the antiviral potency of selected peptides/antibody fragments, and finally provides a discussion about the present status of the developed antivirals in clinic. |
---|---|
MeSH term(s) | Antiviral Agents/pharmacology ; COVID-19/drug therapy ; Cell Surface Display Techniques/methods ; Drug Discovery/methods ; Humans ; Peptide Library ; SARS-CoV-2/drug effects |
Chemical Substances | Antiviral Agents ; Peptide Library |
Language | English |
Publishing date | 2021-06-10 |
Publishing country | Switzerland |
Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Review |
ZDB-ID | 2516098-9 |
ISSN | 1999-4915 ; 1999-4915 |
ISSN (online) | 1999-4915 |
ISSN | 1999-4915 |
DOI | 10.3390/v13061120 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.